Mankind Pharma Limited's receivables is $22B.
Get informed when a big investor buys or sells
+ FollowLatest change versus the prior comparable period (same company).
Mankind Pharma Limited (MANKIND.NS) currently reports a receivables of $22B as of September 2026. That compares with $19B in the prior-year period — up 14.6% year over year. Use the charts on this page to explore Mankind Pharma Limited's receivables history and peer comparisons.
Mankind Pharma Limited's receivables increased from $19B to $22B — a 14.6% year-over-year increase (period ending September 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.
Mankind Pharma Limited reported $22B in receivables as of September 2026. That compares with $19B in the prior-year period — up 14.6% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.
Start with the current receivables of $22B, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Mankind Pharma Limited, and consider following MANKIND.NS for alerts when major investors trade the stock.